Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

In a legal shockwave that will reshape not only New York’s cannabis industry but potentially the entire U.S. market, the Second Circuit’s decision in Variscite NY Four, LLC v. New York State Cannabis Control Board (Aug. 12, 2025) declared that New York’s cannabis licensing preference for those with in-state marijuana convictions is unconstitutional under the Dormant Commerce Clause (DCC).
This ruling—the most consequential Dormant Commerce Clause cannabis decision to date—directly threatens residency- and conviction-based preferences, deepens the circuit split, and places the licensing regimes of multiple states in immediate jeopardy.
The Second Circuit flatly held that New York’s prioritization of applicants with in-state cannabis convictions unlawfully discriminates against out-of-staters. Even under the guise of social equity or restorative justice, the court found such provisions violate the DCC.
The ruling signals that any rule establishing preferential treatment for residents—explicitly or effectively—is unconstitutional. This includes the “significant presence” or principal place of business requirements still deployed in many states.
Several core social equity factors favored by states—including New York—are now legally suspect if they tie eligibility benefits to in-state history, local residence, or state-specific convictions.
"The Dormant Commerce Clause does not tolerate local favoritism, even in the uncharted territory of state-regulated cannabis.” (See full decision)
States using residency, significant in-state presence, or in-state conviction as part of licensing/social equity criteria are now at risk. The Reuters analysis identifies these standouts:
Programs should ensure that no eligibility or selection factor overtly or covertly favors in-state individuals over similarly situated out-of-state applicants.
For ongoing updates, expert guidance, and personalized compliance strategies in the wake of Variscite and other regulatory shifts, visit CannabisRegulations.ai. Stay proactive—regulatory clarity in cannabis has never been more vital.